NMN Bio develops and distributes Nicotinamide Mononucleotide (NMN) supplements that enhance NAD+ levels, a critical coenzyme for cellular energy and metabolism, thereby supporting healthy aging and vitality. The company addresses the decline in NAD+ that occurs with age, which is linked to reduced energy, cognitive function, and increased risk of age-related diseases.
Funding
Funding not disclosed
Founders
Product
Problem
As individuals age, their levels of Nicotinamide Adenine Dinucleotide (NAD+) naturally decline, impacting cellular energy production, metabolism, and overall vitality. This reduction in NAD+ is associated with decreased energy levels, reduced cognitive function, and an increased susceptibility to age-related diseases.
Solution
NMN Bio offers Nicotinamide Mononucleotide (NMN) supplements designed to boost NAD+ levels, supporting healthy aging and overall well-being. Their NMN supplements directly convert into NAD+ within the body, helping to restore cellular energy and function. By increasing NAD+ levels, the supplements aim to combat age-related decline, improve energy and focus, and promote healthy metabolism. NMN Bio's products are third-party tested to ensure pharmaceutical-grade purity, are vegan, allergen-free, and non-GMO.
Target Audience
The primary target audience includes adults over the age of 25 who are experiencing age-related decline in energy, focus, and overall vitality, and who are seeking to support healthy aging.
Features
- Contains Nicotinamide Mononucleotide (NMN), a direct precursor to NAD+
- Designed to boost NAD+ levels, which decline with age
- Supports cellular energy production, metabolism, and overall vitality
- May improve insulin sensitivity in prediabetic women
- May protect against age-related muscle loss in elderly men
- May enhance endurance, aerobic capacity, and cardiovascular fitness
- Third-party tested for pharmaceutical-grade purity (over 99%)
- Vegan, allergen-free, and non-GMO
- Available in capsule form for easy consumption